Status:
UNKNOWN
Individual Acceptance and Commitment Therapy (ACT) for Smoking Cessation for Schizophrenic Patients
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of using Acceptance and commitment therapy for smoking cessation for schizophrenic patients.
Detailed Description
Background: Amongst people with mental disorders, the prevalence of smoking has been reported to be the highest among people with schizophrenia, ranging from 54%-90%. It is more than two to three time...
Eligibility Criteria
Inclusion
- aged 18 years or above;
- diagnosed with schizophrenia;
- referred by medical doctors;
- currently smoking, i.e. have at least one cigarette per day in the past month,
- willing to take part in a face-to-face individual intervention program in changing smoking behaviors such as smoking cessation, reduction of cigarette consumed, or the relief of withdrawal symptoms.
- able to communicate in Cantonese.
Exclusion
- disorientation, developmental disabilities, and/or organic conditions that will inhibit his/her understanding and participation in the therapeutic process,
- diagnosis of alcohol or drug dependence in the preceding year of recruitment or,
- medication regime revised in the last 3 months or,
- current participation in another smoking cessation program.
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2018
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03253445
Start Date
July 1 2014
End Date
June 1 2018
Last Update
August 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Kowloon
Hong Kong, Hong Kong